Smart Money Alert

Biocon Limited

ExitedQuarterly

BIOCONPharmaceuticalsMarket Cap₹57K Cr

Prev stake

1.01%

Holding before

1.65 Cr shares

As of

Sept 2026

Since alert+6.5%₹330.30 → ₹351.80

Nifty 50+1.6%

HDFC Life Insurance

Institution

The move

HDFC Life Insurance has vanished from the latest shareholder list for Biocon Limited, meaning the insurer either fully exited or trimmed its previous 1.01 percent holding below the 1 percent regulatory disclosure threshold.

About Biocon Limited

+ Follow Visit stock

A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.

About HDFC Life Insurance

+ Follow Visit investor

HDFC Life Insurance Company Limited, institutional investor in Indian equities

Get the next move the moment it happens.

Follow HDFC Life Insurance and Biocon Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Biocon Limited shareholders HDFC Life Insurance's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Biocon Limited

LICDecreased

LIC decreased its stake in Biocon Limited from 3.73% to 2.62%, selling 1,80,81,115 shares.

21 Oct 2026

Kotak Mutual FundIncreased

Kotak Mutual Fund increased its stake in Biocon Limited from 1.29% to 2.57%, acquiring 2,09,66,435 shares to bring its total holding to 4,19,58,298 shares.